Success Metrics

Clinical Success Rate

100.0%

Based on 5 completed trials

Completion Rate

100%(5/5)

Active Trials

0(0%)

Results Posted

40%(2 trials)

Phase Distribution

Ph not_applicable

80%

Ph phase_1

20%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 1Safety & dosage

1(20.0%)

N/ANon-phased studies

4(80.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(5)

Detailed Status

Completed5

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 1

Trials by Phase

Phase 11 (20.0%)

N/A4 (80.0%)

Trials by Status

completed5100%

Recent Activity

0 active trials

Showing 5 of 5

completednot_applicable

Clinical Trials (5)

Showing 5 of 5 trials

NCT00853593Not Applicable

Model 4396 Left Ventricular (LV) Lead Study

Completed

NCT01365234Phase 1

Model 20066 Left Ventricular (LV) Lead Study

Completed

NCT00271544Not Applicable

Attain Model 4196 Left Ventricular (LV) Lead

Completed

NCT00269230Not Applicable

Attain StarFix™ Model 4195 Left Ventricular Lead

Completed

NCT00266682Not Applicable

Clinical Investigation of the SelectSecure Pacing Lead

Completed

All 5 trials loaded

Drug Details

Intervention Type: DEVICE
Total Trials: 5